Team Health growth up more than 25% in Q3
Net Revenue is expected to be $899.2m representing 26.2% growth over the third quarter of 2014.
Acquisitions and hybrid acquisitions developed from new hospital contracting opportunities are expected to contribute the majority of net revenue growth between quarters followed by net new sales, and increases in same contract revenue. Within same contract revenue, both fee for service volume and pricing are anticipated to be modestly positive, but growth in pricing will be constrained by declines in Medicaid parity revenue between quarters.
Diluted net earnings per share (EPS) is expected to be $0.48 Adjusted EPS is expected to be$0.68.
Although transaction costs of $2.6 million specifically related to the IPC Healthcaretransaction have been excluded from the calculation of expected Adjusted EPS, an elevated level of other severance costs of $3.3 million, or $0.03 per share, is included in the projected results.
Adjusted EBITDA is expected to increase 13.6% to $101.1m.
The Company is updating its Full Year 2015 outlook for projected net revenue growth from 24.0% - 26.0% to 25.0% - 26.0% and reiterating its Adjusted EBITDA margin of between 10.5% and 11.0%.
IPC Healthcare Transaction.
Transaction remains on track, with closing expected in the fourth quarter of 2015.